US Patent Issued to GENENTECH on Dec. 2 for "Developing an efficient hybridoma platform for therapeutic antibody discovery" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,315, issued on Dec. 2, was assigned to GENENTECH INC. (South San Francisco, Calif.).

"Developing an efficient hybridoma platform for therapeutic antibody discovery" was invented by Meredith Carroll Hazen (South San Francisco, Calif.), Zhonghua Lin (South San Francisco, Calif.) and Dhaya Seshasayee (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The instant technology generally relates to improved methods for producing antibodies, antibody libraries, hybridomas, hybridoma libraries, etc. For example, these methods increase the number of antigen-specific B cells produced, increase the number of hybridomas, and/or increase th...